Back to Search
Start Over
Biotechnological Approaches to Optimize the Production of Amaryllidaceae Alkaloids.
- Source :
-
Biomolecules [Biomolecules] 2022 Jun 25; Vol. 12 (7). Date of Electronic Publication: 2022 Jun 25. - Publication Year :
- 2022
-
Abstract
- Amaryllidaceae alkaloids (AAs) are plant specialized metabolites with therapeutic properties exclusively produced by the Amaryllidaceae plant family. The two most studied representatives of the family are galanthamine, an acetylcholinesterase inhibitor used as a treatment of Alzheimer's disease, and lycorine, displaying potent in vitro and in vivo cytotoxic and antiviral properties. Unfortunately, the variable level of AAs' production in planta restricts most of the pharmaceutical applications. Several biotechnological alternatives, such as in vitro culture or synthetic biology, are being developed to enhance the production and fulfil the increasing demand for these AAs plant-derived drugs. In this review, current biotechnological approaches to produce different types of bioactive AAs are discussed.
Details
- Language :
- English
- ISSN :
- 2218-273X
- Volume :
- 12
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Biomolecules
- Publication Type :
- Academic Journal
- Accession number :
- 35883449
- Full Text :
- https://doi.org/10.3390/biom12070893